- Home
- SCPH
as 07-26-2024 4:00pm EST
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | BURLINGTON |
| Market Cap: | 163.3M | IPO Year: | 2017 |
| Target Price: | $19.00 | AVG Volume (30 days): | 167.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.48 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.24 - $8.55 | Next Earning Date: | 08-08-2024 |
| Revenue: | $17,632,000 | Revenue Growth: | 754.68% |
| Revenue Growth (this year): | 195.21% | Revenue Growth (next year): | 143.33% |
Latest scPharmaceuticals Inc. News
SCPH Breaking Stock News: Dive into SCPH Ticker-Specific Updates for Smart Investing
MT Newswires
a day ago
ScPharmaceuticals New Drug Application Seeking to Expand Furoscix Indication Accepted for Filing by FDA
GlobeNewswire
a day ago
scPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (sNDA) Seeking to Expand FUROSCIX Indication to Include Chronic Kidney Disease
Simply Wall St.
2 days ago
When Will scPharmaceuticals Inc. (NASDAQ:SCPH) Breakeven?
GOBankingRates
2 months ago
5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
AFP
2 months ago
Bumrah delivers as India beat Pakistan in low-scoring thriller
AFP
2 months ago
Italy beat Bosnia in final Euros warm-up
AFP
2 months ago
Trump loyalists proud to support 'felon' at Las Vegas rally
Business Insider
2 months ago
US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
Compare SCPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SCPH scPharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.